Identification of functional polymorphisms of the thromboxane A2 receptor gene in healthy volunteers

Summary

Thromboxane A2 receptor (TP) is an important actor in vascular physiology and plays a crucial role in the platelet activation process. Genetic polymorphisms of the gene coding for the TP have been described, but their impacts on platelet function tests are unknown. The aim of this study was to investigate the relationship between genetic polymorphisms of the coding sequence of the TP gene and platelet function tests. We investigated 100 healthy volunteers twice, one week apart by performing platelet aggregation and secretion tests. We sequenced the coding region of the TP gene and confronted the genetic variants with the phenotypic results. We identified five single nucleotide polymorphisms (SNP); one of them, T1712C, replaces Leu by Pro at position 133 of the isoform β of the TP. Homozygosity for the minor allele of the C795T, C924T or the G1686A SNP was associated with a decreased expression of CD62P when platelets were stimulated with the TP agonist U46619. As C795T and C924T have been linked to clinical disorders in which TxA2 plays a key role, the possible role of the G1686A and T1712C SNP should also be examined in selected diseases.

Keywords

Genetics - platelet - polymorphisms - thromboxane - TP

• References

• 1 Narumiya S. Prostanoid receptors. Structure, function, and distribution. Ann NY Acad Sci 1994; 744: 126-38.
• 2 Breyer RM, Bagdassarian CK, Myers SA. et al. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001; 41: 661-90.
• 3 Audoly LP, Rocca B, Fabre JE. et al. Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo . Circulation 2000; 101: 2833-40.
• 4 Arita H, Nakano T, Hanasaki K. Thromboxane A2: its generation and role in platelet activation. Prog Lipid Res 1989; 28: 273-301.
• 5 Takahara K, Murray R, FitzGerald GA. et al. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems. J Biol Chem 1990; 265: 6836-44.
• 6 Dorn 2nd GW, Becker MW, Davis MG. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J Biol Chem 1992; 267: 24897-905.
• 7 Hanasaki K, Nakano T, Arita H. Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells. Biochem Pharmacol 1990; 40: 2535-42.
• 8 Hirata M, Hayashi Y, Ushikubi F. et al. Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 1991; 349: 617-20.
• 9 Raychowdhury MK, Yukawa M, Collins LJ. et al. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J Biol Chem 1994; 269: 19256-61.
• 10 Hirata T, Ushikubi F, Kakizuka A. et al. Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest 1996; 97: 949-56.
• 11 Habib A, FitzGerald GA, Maclouf J. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. J Biol Chem 1999; 274: 2645-51.
• 12 Nusing RM, Hirata M, Kakizuka A. et al. Characterization and chromosomal mapping of the human thromboxane A2 receptor gene. J Biol Chem 1993; 268: 25253-9.
• 13 Saunders AM, Strittmatter WJ, Schmechel D. et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 1993; 43: 1467-72.
• 14 Bertina RM, Koeleman BP, Koster T. et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
• 15 Tanaka K, Roberts MH, Yamamoto N. et al. Genetic variants of the receptors for thromboxane A2 and IL-4 in atopic dermatitis. Biochem Biophys Res Commun 2002; 292: 776-80.
• 16 Unoki M, Furuta S, Onouchi Y. et al. Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association a T924C polymorphism in the thromboxane A2 receptor gene. Hum Genet 2000; 106: 440-6.
• 17 Hong SJ, Lee SY, Kim HB. et al. IL-5 and thromboxane A2 receptor gene polymorphisms are associated with decreased pulmonary function in Korean children with atopic asthma. J Allergy Clin Immunol 2005; 115: 758-63.
• 18 Kim SH, Choi JH, Park HS. et al. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy 2005; 35: 585-90.
• 19 Hirata T, Kakizuka A, Ushikubi F. et al. Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J Clin Invest 1994; 94: 1662-7.
• 20 Gaussem P, Reny JL, Thalamas C. et al. The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies. J Thromb Haemost 2005; 03: 1437-45.
• 21 Worth NF, Berry CL, Thomas AC. et al. S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbits. Atherosclerosis 2005; 183: 65-73.
• 22 Dupont A, Fontana P, Bachelot-Loza C. et al. An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood 2003; 101: 1833-40.
• 23 Fontana P, Dupont A, Gandrille S. et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 2003; 108: 989-95.
• 24 Lin L, Torbeck LD. Coefficient of accuracy and concordance correlation coefficient: new statistics for methods comparison. PDA J Pharm Sci Technol 1998; 52: 55-9.
• 25 D’Agostino RB, Balanger A, D’Agostino RBJ. A suggestion for using powerful and informative tests of normality. Am Statistician 1990; 44: 316-21.